Invention Grant
- Patent Title: Cyclic dinucleotides as anticancer agents
-
Application No.: US16642440Application Date: 2018-08-30
-
Publication No.: US11667663B2Publication Date: 2023-06-06
- Inventor: Lalgudi S. Harikrishnan , Muthoni G. Kamau , Xiao Zhu
- Applicant: BRISTOL-MYERS SQUIBB COMPANY
- Applicant Address: US NJ Princeton
- Assignee: Bristol-Myers Squibb Company
- Current Assignee: Bristol-Myers Squibb Company
- Current Assignee Address: US NJ Princeton
- Agent Elliott Korsen
- International Application: PCT/US2018/048658 2018.08.30
- International Announcement: WO2019/046496A 2019.03.07
- Date entered country: 2020-02-27
- Main IPC: C07H21/02
- IPC: C07H21/02 ; C07K16/28 ; A61K39/00
Abstract:
The present invention is directed to compounds of the formula
wherein all substituents are defined herein, as well as pharmaceutically acceptable compositions comprising compounds of the invention and methods of using said compositions in the treatment of various disorders.
wherein all substituents are defined herein, as well as pharmaceutically acceptable compositions comprising compounds of the invention and methods of using said compositions in the treatment of various disorders.
Public/Granted literature
- US20200270298A1 CYCLIC DINUCLEOTIDES AS ANTICANCER AGENTS Public/Granted day:2020-08-27
Information query
